Northwest Biotherapeutics reported 11.67 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AstraZeneca 27.29 5.8 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eisai 26.63 0.46 Dec/2025
Merck 13.92 5.08 Dec/2025
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Pfizer 14.48 5.18 Dec/2025
Roche Holding 16.09 3.51 Dec/2025